Sander van der Marel

986 total citations
24 papers, 599 citations indexed

About

Sander van der Marel is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Sander van der Marel has authored 24 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Sander van der Marel's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (13 papers) and Virus-based gene therapy research (3 papers). Sander van der Marel is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (13 papers) and Virus-based gene therapy research (3 papers). Sander van der Marel collaborates with scholars based in Netherlands, Canada and United States. Sander van der Marel's co-authors include Daniël W. Hommes, Gijs R. van den Brink, Jeroen Maljaars, Marjolijn Duijvestein, Andrea E. van der Meulen‐de Jong, Herma H. Fidder, Roeland A. Veenendaal, James C.H. Hardwick, Valérie Ferreira and Frank Hoentjen and has published in prestigious journals such as Nutrients, World Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Sander van der Marel

21 papers receiving 589 citations

Peers

Sander van der Marel

GENET

EPIDE

SURGE

IMMUN

Sara Renna Italy

Erika Angelucci Italy

Jami Kinnucan United States

Ian Shaw United Kingdom

Lisa W. Datta United States

Rizwan Ahmed United States

Cheryl Young United States

Isabel Bernal Spain

Ola Niewiadomski Australia

Daniela Simian Chile

Sara Renna Italy

Sander van der Marel

530 ×1.5

GENET

449 ×2.0

EPIDE

168 ×1.4

SURGE

58 ×0.5

150 ×1.4

IMMUN

Citations per year, relative to Sander van der Marel Sander van der Marel (= 1×) peers Sara Renna

Countries citing papers authored by Sander van der Marel

Since Specialization

Citations

This map shows the geographic impact of Sander van der Marel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander van der Marel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander van der Marel more than expected).

Fields of papers citing papers by Sander van der Marel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander van der Marel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander van der Marel. The network helps show where Sander van der Marel may publish in the future.

Co-authorship network of co-authors of Sander van der Marel

This figure shows the co-authorship network connecting the top 25 collaborators of Sander van der Marel. A scholar is included among the top collaborators of Sander van der Marel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander van der Marel. Sander van der Marel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mujagic, Zlatan, Annemarie C. de Vries, Andrea E. van der Meulen‐de Jong, et al.. (2025). Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study. Digestive Diseases and Sciences. 70(8). 2786–2793. 2 indexed citations

Stuyt, Rogier J. L., Sander van der Marel, Rutger J. Jacobs, et al.. (2024). Deficits in geriatric assessment are important in relation to fatigue in older patients with Inflammatory Bowel Disease. Digestive and Liver Disease. 56(9). 1490–1496. 2 indexed citations

Voorneveld, Philip W., et al.. (2024). Multimodal Lifestyle Intervention Improves Fatigue in Quiescent Inflammatory Bowel Disease: A Controlled Study. Crohn s & Colitis 360. 7(1). otaf009–otaf009.

Camps, María Teresa, Gerard Dijkstra, Sander van der Marel, et al.. (2024). P190 Identification of clinical risk factors for postoperative endoscopic recurrence in Crohn’s disease: a prospective, multicenter cohort study. Journal of Crohn s and Colitis. 18(Supplement_1). i498–i498.

Nooij, Sam, Elisabeth M. Terveer, Emily Crossette, et al.. (2024). Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study. Journal of Crohn s and Colitis. 18(9). 1381–1393. 14 indexed citations

Ruler, Oddeke van, Laurents Stassen, Gerard Dijkstra, et al.. (2023). Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn’s disease are not incorporated in routine care. International Journal of Colorectal Disease. 38(1). 254–254. 2 indexed citations

Steege, Rinze W. F. ter, Greetje J. Tack, Johan P. Kuyvenhoven, et al.. (2022). Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed. Journal of Clinical Medicine. 11(22). 6843–6843. 11 indexed citations

Steege, Rinze W. F. ter, Greetje J. Tack, Johan P. Kuyvenhoven, et al.. (2022). P687 Prevalence of iron deficiency and anaemia in the outpatient Inflammatory Bowel Disease population: a Dutch national cross-sectional study. Journal of Crohn s and Colitis. 16(Supplement_1). i589–i589.

Biemans, Vince, Frank Hoentjen, Nanne K.H. de Boer, et al.. (2021). Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study. Journal of Crohn s and Colitis. 15(11). 1920–1930. 26 indexed citations

10.

Steenhuis, Maurice, et al.. (2021). Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up. International Journal of Colorectal Disease. 37(2). 349–356. 9 indexed citations

11.

Biemans, Vince, Marieke Pierik, Gerard Dijkstra, et al.. (2020). Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics. 52(8). 1366–1376. 29 indexed citations

12.

Torres, Joana, Pierre Ellul, Jost Langhorst, et al.. (2019). European Crohn’s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 13(6). 673–685e. 94 indexed citations

13.

Biemans, Vince, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude, et al.. (2019). Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study. Journal of Crohn s and Colitis. 14(1). 33–45. 125 indexed citations

14.

Molendijk, Ilse, Sander van der Marel, & Jeroen Maljaars. (2019). Towards a Food Pharmacy: Immunologic Modulation through Diet. Nutrients. 11(6). 1239–1239. 27 indexed citations

15.

Marel, Sander van der. (2012). Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis. World Journal of Gastroenterology. 18(32). 4288–4288. 18 indexed citations

16.

Marel, Sander van der, Anje A. te Velde, Sybren L. Meijer, et al.. (2012). Murine CD4+CD25- cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo. BMC Gastroenterology. 12(1). 172–172. 11 indexed citations

17.

Cousens, Leslie P., Federico Mingozzi, Sander van der Marel, et al.. (2012). Teaching tolerance. Human Vaccines & Immunotherapeutics. 8(10). 1459–1464. 15 indexed citations

18.

Marel, Sander van der. (2011). Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World Journal of Gastrointestinal Pathophysiology. 2(6). 114–114. 26 indexed citations

19.

Marel, Sander van der, Hein W. Verspaget, Sander van Deventer, et al.. (2011). Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: Implications for gene therapy. Inflammatory Bowel Diseases. 17(12). 2436–2442. 28 indexed citations

20.

Marel, Sander van der, Marjolijn Duijvestein, James C.H. Hardwick, et al.. (2009). Quality of web-based information on inflammatory bowel diseases. Inflammatory Bowel Diseases. 15(12). 1891–1896. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact